Cytotoxicological pathways induced after nanoparticle exposure: studies of oxidative stress at the 'nano-bio' interface.

Abstract

Nanotechnology is advancing rapidly; many industries are utilizing nanomaterials because of their remarkable properties. As of 2017, over 1800 "nano-enabled products" (i.e. products that incorporate a nanomaterial feature and alter the product's performance) have been used to revolutionize pharmaceutical, transportation, and agriculture industries, just to name a few. As the number of nano-enabled products continues to increase, the risk of nanoparticle exposure to humans and the surrounding environment also increases. These exposures are usually classified as either intentional or unintentional. The increased rate of potential nanoparticle exposure to humans has required the field of 'nanotoxicology' to rapidly screen for key biological, biochemical, chemical, or physical signals, signatures, or markers associated with specific toxicological pathways of injury within in vivo, in vitro, and ex vivo models. One of the common goals of nanotoxicology research is to identify critical perturbed biological pathways that can lead to an adverse outcome. This review focuses on the most common toxicological pathways induced by nanoparticle exposure and provides insights into how these perturbations could aid in the development of nanomaterial specific adverse outcomes, inform nano-enabled product development, ensure safe manufacturing practices, promote intentional product use, and avoid environmental health hazards.